We are a health-focused technology company developing simple, smart and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future.
We are developing a proprietary platform that uses Radio Frequency (“RF”) technology, which we believe will enable the creation of low-cost and scalable sensors that are small enough to fit into a wearable and other small form factors. We expect that our platform will provide users with the ability to measure and continuously monitor vital health data and provide actionable feedback to jumpstart changes in behaviors.
Our platform is the foundation for our first product in development, which is a non-invasive and cuffless wearable that simultaneously measures glucose, blood pressure and heart rate. It is intended to combine the functionality of a continuous glucose monitor (“CGM”) and a cuffless RF-based blood pressure monitor (“rBPM ®”) into one wearable device. Once developed, we believe it will allow users to manage their health with confidence and in a manner that best fits their lifestyle, ultimately improving health outcomes.
(Note: Movano upsized its IPO at pricing on March 22, 2021, by pricing 8.5 million shares at $5 each to raise $42.5 million. The company filed with the SEC on March 23, 2021, to register more shares to increase the size of the deal from the 7.2 million shares in the prospectus.)
|Industry:||Electromedical & Electrotherapeutic Apparatus|
|Address||6200 Stoneridge Mall Rd., Suite 300 Pleasanton, CA 94588|
|Phone Number||(415) 651-3172|
|View Prospectus:||Movano Inc.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$-13.0 mil (last 12 months)|
|Price range||$5.00 - $5.00|
|Est. $ Volume||$42.5 mil|
|Manager / Joint Managers||National Securities Corp.|
|Expected To Trade:||3/23/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|